Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Treasury Shares (2022 - 2025)

Gossamer Bio's Treasury Shares history spans 4 years, with the latest figure at $4.1 million for Q4 2025.

  • For Q4 2025, Treasury Shares changed N/A year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, changed N/A, while the annual FY2025 figure was $4.1 million, N/A changed from the prior year.
  • Treasury Shares reached $4.1 million in Q4 2025 per GOSS's latest filing, up from $2.7 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $4.1 million in Q4 2025 to a low of $8606.0 in Q1 2024.
  • Average Treasury Shares over 4 years is $1.5 million, with a median of $1.4 million recorded in 2022.
  • Peak YoY movement for Treasury Shares: crashed 68.32% in 2023, then crashed 98.42% in 2024.
  • A 4-year view of Treasury Shares shows it stood at $1.4 million in 2022, then plummeted by 68.32% to $427698.0 in 2023, then plummeted by 97.99% to $8606.0 in 2024, then surged by 47854.47% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Treasury Shares are $4.1 million (Q4 2025), $2.7 million (Q3 2025), and $8606.0 (Q1 2024).